Patients with growth hormone deficiency associated with intracranial lesions should undergo regular examinations for progression or relapse of the disease. The New England Journal of Medicine published two editorials rein 2003 expressing concern about off-label uses of HGH and the proliferation of advertisements for "HGH-Releasing" dietary supplem